Trinity Biotech
TRIB
Trinity Biotech (TRIB) earnings history
Most recent quarter
- Fiscal period
- Q4 2024
- Period end
- Dec 31, 2024
- EPS actual
- −$37.06
- EPS estimate
- −$9.00
- EPS surprise
- −311.83%
- Revenue surprise
- −3.90%
- Revenue
- $15.9M
- Revenue estimate
- $16.5M
- Reported
- May 15, 2025
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q4 2024 | May 15, 2025 | −$9.00 | −$37.06 | −311.83% | $15.9M | SEC |
| Q3 2024 | Nov 15, 2024 | −$16.20 | −$13.74 | +15.15% | $15.2M | SEC |
| Q2 2024 | Aug 20, 2024 | −$20.10 | −$21.42 | −6.55% | $15.8M | SEC |
| Q1 2024 | May 28, 2024 | −$18.00 | −$11.22 | +37.67% | $14.7M | SEC |
| Q4 2023 | Apr 5, 2024 | −$21.00 | −$21.53 | −2.54% | $13.4M | SEC |
| Q2 2023 | Oct 6, 2023 | −$13.50 | −$71.88 | −432.46% | $13.9M | SEC |
| Q1 2023 | Jul 10, 2023 | −$9.00 | −$24.78 | −175.39% | $14.8M | SEC |
| Q4 2022 | Mar 27, 2023 | −$9.00 | −$39.75 | −341.67% | $18.0M | SEC |
| Q3 2022 | Dec 16, 2022 | −$6.00 | −$35.21 | −486.76% | $19.5M | — |
| Q2 2022 | Nov 4, 2022 | −$4.50 | −$42.88 | −852.81% | $18.5M | — |
| Q1 2022 | Jul 1, 2022 | −$6.00 | −$11.73 | −95.42% | $18.8M | — |
| Q4 2021 | Apr 11, 2022 | $10.50 | $9.55 | −9.07% | $19.5M | — |
| Q3 2021 | Dec 16, 2021 | $12.00 | $7.33 | −38.92% | $22.0M | — |
| Q2 2021 | Sep 9, 2021 | $10.50 | $31.80 | +202.86% | $25.8M | — |
| Q1 2021 | May 27, 2021 | $9.00 | $15.15 | +68.33% | $25.6M | — |
| Q4 2020 | Mar 26, 2021 | $21.00 | $53.85 | +156.43% | $32.8M | — |
| Q3 2020 | Nov 17, 2020 | $15.00 | $52.50 | +250.00% | $32.0M | — |
| Q2 2020 | Aug 25, 2020 | $0.00 | −$5.40 | +0.00% | $16.0M | — |
| Q1 2020 | May 27, 2020 | $4.50 | $7.95 | +76.67% | $21.2M | — |
Quarterly revenue
Frequently asked questions
When did Trinity Biotech (TRIB) last report earnings?
Trinity Biotech last reported on May 15, 2025, covering fiscal Q4 2024.
Did TRIB beat earnings estimates?
No. Trinity Biotech reported EPS of −$37.06 for Q4 2024 against a −$9.00 estimate — a 311.83% miss.
How much revenue did TRIB report last quarter?
Trinity Biotech reported $15.9M in revenue for Q4 2024, against a consensus estimate of $16.5M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.